The urgent need for effective therapeutics to limit the damage of COVID-19
The Access to COVID-19 Tools (ACT) Accelerator was launched in April 2020 by the World Health Organization and a range of global partners. The aim of this new collaboration is to make vaccines, diagnostics and therapeutics for COVID-19 accessible to everyone who needs them worldwide.
Unitaid is pleased to work alongside Wellcome as co-convenors of the Therapeutics Partnership in driving the work around development, manufacturing, procurement and deployment of treatments.
Given the close link between testing and treating in the COVID-19 response, Unitaid also participates in the Diagnostics Partnership, where it co-leads the work on ensuring market readiness. It is also engaged in activities for health systems strengthening as part of its work to ensure equitable access.
This page gives details of the different interventions that Unitaid is making to support the global efforts.
- The Access to COVID-19 Tools (ACT) frequently asked questions, WHO
- ACT-Accelerator Investment Case, WHO
- Consolidated Investment Case, WHO
- Therapeutics Partnership Investment Case
- Diagnostics Partnership Investment Case
- Vaccines Partnership Investment Case
LIVE: #COVID19 ACT-Accelerator Technical Update and Press Briefing with @DrTedros https://t.co/vpj8dHvMj8
— World Health Organization (WHO) (@WHO) June 26, 2020
- ACT-Accelerator moves to expand access to dexamethasone for low- and middle-income countries for COVID-19 treatment, Unitaid, 3.7.2020
- ‘Global Goal: Unite for Our Future,’ Global Citizen and The European Commission Mobilize $1.5 Billion In Cash Grants, and $5.4 Billion In Loans and Guarantees—For A Total Of $6.9 Billion Pledged—To Combat the Disproportionate Impact of Covid-19 On Vulnerable and Disadvantaged Communities, Global Citizen, 27.7.2020
- Act-Accelerator update, WHO, 26.6.2020
UNITAID Is Fighting Against COVID-19 Through Collaboration
Global Goal: Unite for Our Future
Global Goal: Unite For Our Future* | The Concert
Streamed live on 27 June 2020
*The campaign calls on world leaders, corporations, and philanthropists to commit the funds necessary to ensure there are enough tests, treatments, and vaccines to equitably reach everyone, everywhere in the world.
These funds will go to organizations that collectively make up the World Health Organization’s (WHO) ACT Accelerator, specializing in the development, production, and delivery of tests, treatments, and vaccines.
Coalition for Epidemic Preparedness Innovations (CEPI)
Gavi, the Vaccine Alliance
The Therapeutics Accelerator
The Foundation for Innovative New Diagnostics (FIND)
The Global Fund
World Health Organization
For the latest news, follow the @UNITAID on Twitter
Martin HARVEY | +41 79 249 35 29 | firstname.lastname@example.org
Other enquiries click here